Aminotransferase; Antiviral Therapy; Chronic Hepatitis B; Liver Neoplasms; Treatment; Viruses; Antiviral Agents; Antiviral Agents/therapeutic use; Hepatitis B virus; Hepatitis B, Chronic/drug therapy; Humans; General Medicine
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Khosravi, Mohammad Hossein ; Université de Liège - ULiège ; Students' Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran., Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Alavian, Seyed Moayed ; Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Language :
English
Title :
Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
Lee J, Sinn DH, Kim JH, Gwak GY, Kim HS, Jung SH, Paik YH, Choi MS, Lee JH, Koh KC, et al. Hepatocellular carcinoma risk of compensated cirrhosis patients with elevated HBV DNA levels according to serum aminotransferase levels. J Korean Med Sci 2015; 30: 1618-24.
Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am K Gastroenterol 2008; 103: 1663-73.
Vanni E, Bugianesi E. Obesity and liver cancer. Clinics Liver Dis 2014; 18: 191-203.
Keshvari M, Alavian SM, Sharafi H. How can we make decision for patients with chronic hepatitis B according to hepatitis B virus (HBV) DNA level? Hepat Mon 2014; 14: e15285.
Cho JY, Paik YH, Sohn W, Cho HC, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease. Gut 2014; 63: 1943-50.
Sali S, Sharafi H, Alavian SH, Alavian SM, Etesam F, Salimi S, Merza MA, Keshvari M. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state? Diagn Microbiol Infect Dis 2015; 82: 114-9.
